How High Can Clovis Oncology, Inc. (CLVS) Reach?

Clovis Oncology, Inc. (CLVS) has seen some recent volatility in the marketplace and its shares were last quoted at $6.47 yesterday. Investors are starting to take notice of CLVS as the shares traded as high as $6.48 and as low as $6.25 in the previous market session.

Clovis Oncology, Inc. (CLVS) average trading volume is 6.16M. However, in the previous market session Clovis Oncology, Inc. (CLVS) traded 2,745,072 shares. The First support level on CLVS is $3.76 and the First upside resistance level on CLVS is $11.00. CLVS 50-day moving average is $6.58 and CLVS two hundred day moving average is $7.39.

Clovis Oncology, Inc. (CLVS) most current performance has been shown by the recent movement in CLVS shares. CLVS has performed -1.75% over the past 30 days, CLVS has performed -19.89% over the past quarter and CLVS has shown -31.37% over the past 12 months. Clovis Oncology, Inc. (CLVS) has a 52 week range of $2.93 to $17.37. Clovis Oncology, Inc. (CLVS) is trading 120.65% from its 52 week low and -62.78% from its 52 week high. Clovis Oncology, Inc. (CLVS) is showing a 46.83% short float showing the sum short in the float.

CLVS has 71.66M shares outstanding and 69.72M shares in the float. Clovis Oncology, Inc. (CLVS) at this time has a market cap of $602.73M and income of -413.30M. The EPS next quarter for CLVS is -1.04 and projected EPS next year is 42.40%. The market cap of Clovis Oncology, Inc. (CLVS) at $602.73M represents how many Investors own shares of CLVS and is calculated off the last price ($6.47) of CLVS and the sum of shares outstanding (71.66M) with Clovis Oncology, Inc. (CLVS).

Clovis Oncology, Inc. (CLVS) has aggregate cash (mrq) of 228.36M, aggregate cash per share (mrq) of 2.97, aggregate debt of CLVS remains at 610.45M. Clovis Oncology, Inc. (CLVS) operating cash flow (ttm) is -307.66M, CLVS leveraged free cash flow (ttm) is -152.2M.

CLVS is trading 2.20% above (bullish) its SMA20, -3.63% below (bearish) its SMA50 and -16.44% below (bearish) its SMA200.

Related Articles

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Get in Touch

19,000FansLike
35,222FollowersFollow
22,458FollowersFollow

Latest Posts

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Fuwei (NASDAQ: FFHL) Plans To Sell Dornier Production Line

Fuwei Films (Holdings) Co., Ltd. (NASDAQ: FFHL) recently declared that it will be closing its Dornier line of production as early as possible. Fuwei...

PPG Industries (NYSE: PPG) Announces Accquisition Of Ennis-Flint

PPG Industries, Inc. (NYSE: PPG) is planning to buy Ennis-Flint in a deal valued at nearly $1.15 billion. The decision to acquire Ennis-Flint will...